News Related to Center for Cell-Based Therapy

Related coverage linked through entity extraction aliases.

New Engineering Strategies Boost CAR-NK and CAR-T Cell Therapies Against Cancer

Feb 28, 2026

Recent studies demonstrate significant advances in engineered immune cell therapies, including enhanced CAR-T cells for solid tumors through NR2F6 deletion and mass production of CAR-NK cells from cord blood stem cells capable of generating millions of tumor-killing cells.

Next-Generation CAR-T and CAR-NK Cell Therapies Show Promise in Cancer Treatment

Feb 25, 2026

Recent advances in chimeric antigen receptor cell therapies highlight improved designs for CAR-T and CAR-NK treatments, with new strategies addressing efficacy and safety challenges in both hematologic and solid tumors.